Cancer researcher Lloyd Old, who pioneered the field of cancer immunotherapy, died this week from prostate cancer, reports The New York Times. He was 78. He held a number of posts in his lifetime, including at Memorial Sloan-Kettering Cancer Center and at the Ludwig Institute for Cancer Research. Old studied the links between cancer and the immune system, and made it possible for others to develop cancer-fighting vaccines, the Times says.
Lloyd Old Dies
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.